FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study
WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor …